SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Aclaris Therapeutics, Inc. (ACRS)

ACRS RSS Feed
Add ACRS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/6/2016 11:44:47 AM - Followers: 1 - Board type: Free - Posts Today: 0

Aclaris Therapeutics, Inc. 101 Lindenwood Drive Suite 400 Malvern, PA 19355 United States 484-324-7933 http://www.aclaristx.com Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
ACRS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
ACRS News: Aclaris Therapeutics Initiates Phase 2b Clinical Trials of A-101 for Topical Treatment of Common Warts 06/29/2017 08:00:00 AM
ACRS News: Statement of Changes in Beneficial Ownership (4) 06/16/2017 07:48:29 PM
ACRS News: Statement of Changes in Beneficial Ownership (4) 06/16/2017 07:47:31 PM
ACRS News: Statement of Changes in Beneficial Ownership (4) 06/16/2017 07:46:23 PM
ACRS News: Statement of Changes in Beneficial Ownership (4) 06/16/2017 07:45:27 PM
PostSubject
#1   ACRS bullish 22.07 stocktrademan 09/06/16 11:44:47 AM
PostSubject